Discover how the acellular collagen matrix mucoderm® from botiss biomaterials provides a safe and effective alternative to autologous soft tissue grafts. Thanks to a multi-step purification process, mucoderm® preserves a native collagen structure (types I and III) that allows rapid vascularization and is completely remodeled into the patient’s own connective tissue within 6–9 months. Indications include soft tissue augmentation around implants, increasing the width of keratinized gingiva, and root coverage procedures – especially in cases where harvesting autologous tissue is limited. For more details about mucoderm® and to explore numerous clinical cases and surgical applications, visit our website: https://botiss.com/product/mucoderm/ – where you’ll find a wide range of Cases & Surgeries showcasing mucoderm® in practice.